The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Is There a Future for Neuropeptide Receptor Ligands in the Treatment of Anxiety Disorders?
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965
Animal models of ‘anxiety’: Where next?
Rodgers, R. J. (1997) · Behavioural Pharmacology · doi:10.1097/00008877-199711000-00003 · Cited by 437 · cited 1×
“However, the use of different experimental procedures may account for this variability, since there is now growing evidence that different animal models of anxiolytic activity actually may be measuring different facets of anxiety (Rodgers, 1997; Ramos and Mormede, 1998).”
BackgroundRassnick, S., Heinrichs, S. C., Britton, K. T., & Koob, G. F. (1993) · Brain Research · doi:10.1016/0006-8993(93)91352-s · Cited by 407
Butler, P., Weiss, J., Stout, J., & Nemeroff, C. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-01-00176.1990 · Cited by 402
Corticotropin-releasing factor potentiates acoustic startle in rats: Blockade by chlordiazepoxide
Swerdlow, N. R., Geyer, M. A., Vale, W. W., & Koob, G. F. (1986) · Psychopharmacology · doi:10.1007/bf00652231 · Cited by 299
Sarnyai, Z., Bíró, É., Gardi, J., Vecsernyés, M., Julesz, J., & Telegdy, G. (1995) · Brain Research · doi:10.1016/0006-8993(95)00043-p · Cited by 255
Liebsch, G., Landgraf, R., Gerstberger, R., Probst, J. C., Wotjak, C. T., Engelmann, M., Holsboer, F., & Montkowski, A. (1995) · Regulatory Peptides · doi:10.1016/0167-0115(95)00099-w · Cited by 220 · cited 1×
“Moreover, reductions in anxiety-related behavior were observed after chronic infusion of CRF1 receptor antisense oligonucleotides into the central nucleus of the amygdala (Liebsch et al., 1995).”
BackgroundCorticotropin-releasing factor administered intraventricularly to rhesus monkeys
Kalin, N. H., Shelton, S. E., Kraemer, G. W., & McKinney, W. T. (1983) · Peptides · doi:10.1016/0196-9781(83)90117-1 · Cited by 101
Kalin, N. H., & Takahashi, L. K. (1990) · Brain Research · doi:10.1016/0006-8993(90)90311-x · Cited by 59
Cited by
The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review
Prut, L., & Belzung, C. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01272-x · Cited by 3,175
The neurobiology and control of anxious states
Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 965
Neuroendocrine pharmacology of stress
Carrasco, G. A., & Van de Kar, L. D. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01285-8 · Cited by 914
Measuring normal and pathological anxiety-like behaviour in mice: a review
Belzung, C., & Griebel, G. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00291-1 · Cited by 912
Self-citation50 years of hurdles and hope in anxiolytic drug discovery
Griebel, G., & Holmes, A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4075 · Cited by 414
Self-citation
Metadata
- Authors
- Griebel, G.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 1999-04
- Volume
- 82
- Issue
- 1
- Pages
- 1-61
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W1977665929
- Cited by
- 171
- References
- 9
- FWCI
- 4.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Is There a Future for Neuropeptide Receptor Ligands in the Treatment of Anxiety Disorders? https://app.cochat.ai/papers/10.1016/s0163-7258(98)00041-2
- The paper
- Griebel, G. (1999). Is There a Future for Neuropeptide Receptor Ligands in the Treatment of Anxiety Disorders? Pharmacology & Therapeutics. https://doi.org/10.1016/s0163-7258(98)00041-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
